Topical treatments for irritated eyes with an eye prosthesis
Treatments studied
Part of Eyes & vision clinical trials.
This Phase 3 study compares two topical (applied to the eye) treatments to reduce inflammation-related irritation in people who wear a permanent eye prosthesis. It may help if your prosthesis-related eye discomfort is ongoing despite basic care like artificial tears.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have had a permanent eye prosthesis in place for more than 6 months
- Your eye irritation score (Modified OSDI) is at least 20 out of 40
- You have health insurance and can give written consent
- If you can become pregnant, you will use reliable birth control during the study and for 1 week after the last dose
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new anti-inflammatory eye drop (PRO-232) in people who had routine cataract surgery on one eye the day before. The goal is to see if it helps control swelling and pain without problems.
This Phase 4 study looks at a treatment plan around the time of planned surgery on both eyes (called RLE). It may help the researchers learn how safe and effective the approach is for improving eye outcomes after surgery.
This study looks at how certain glaucoma eye drops affect the surface of your eye. It tests a new implant that may reduce damage and improve comfort.
This trial tests a medical device eye ointment called Vit-A-Vision for people with dry eye disease. It aims to see if the ointment can improve symptoms and tear film stability over about a month.
This study tests whether a new eye drop (rhPRG4) can safely reduce dry eye symptoms caused by graft-versus-host disease (GVHD). It compares the active drops to an inactive placebo to see if they provide better relief.
This study tests two types of preservative-free eye drops to see which is more effective for people with mild to moderate dry eye disease. You will use one of the drops as directed, and the study will monitor your symptoms and eye health over time.
Hear when a new Ocular Inflammation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.